New ultrasound tech aims to sharpen cancer detection

NCT ID NCT07225114

First seen Nov 05, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study is testing a new imaging method called Contrast Enhanced Super-Resolution (CESR) ultrasound to see if it can better find cancer in the breast, liver, and kidney. About 40 people will take part: 30 patients with known lesions and 10 healthy volunteers to help fine-tune the system. The goal is to compare CESR results with standard ultrasound and biopsy findings to see if it improves accuracy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of North Carolina

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.